Free Trial
NASDAQ:NERV

Minerva Neurosciences (NERV) Stock Price, News & Analysis

Minerva Neurosciences logo
$1.76 -0.04 (-1.98%)
Closing price 04:00 PM Eastern
Extended Trading
$1.78 +0.02 (+1.14%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Minerva Neurosciences Stock (NASDAQ:NERV)

Key Stats

Today's Range
$1.76
$1.79
50-Day Range
$1.56
$2.17
52-Week Range
$1.15
$3.00
Volume
905 shs
Average Volume
23,020 shs
Market Capitalization
$12.30 million
P/E Ratio
2.15
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Minerva Neurosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

NERV MarketRank™: 

Minerva Neurosciences scored higher than 55% of companies evaluated by MarketBeat, and ranked 459th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Minerva Neurosciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Minerva Neurosciences has received no research coverage in the past 90 days.

  • Read more about Minerva Neurosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Minerva Neurosciences are expected to decrease in the coming year, from ($0.30) to ($2.68) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Minerva Neurosciences is 2.15, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.93.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Minerva Neurosciences is 2.15, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.04.

  • Percentage of Shares Shorted

    0.52% of the float of Minerva Neurosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Minerva Neurosciences has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Minerva Neurosciences has recently increased by 3.28%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Minerva Neurosciences does not currently pay a dividend.

  • Dividend Growth

    Minerva Neurosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.52% of the float of Minerva Neurosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Minerva Neurosciences has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Minerva Neurosciences has recently increased by 3.28%, indicating that investor sentiment is decreasing.
    • Insider Buying vs. Insider Selling

      In the past three months, Minerva Neurosciences insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 8.60% of the stock of Minerva Neurosciences is held by insiders.

    • Percentage Held by Institutions

      Only 34.56% of the stock of Minerva Neurosciences is held by institutions.

    • Read more about Minerva Neurosciences' insider trading history.
    Receive NERV Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

    NERV Stock News Headlines

    Amazon’s big Bitcoin embarrassment
    Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
    See More Headlines

    NERV Stock Analysis - Frequently Asked Questions

    Minerva Neurosciences' stock was trading at $2.22 on January 1st, 2025. Since then, NERV stock has decreased by 20.7% and is now trading at $1.76.

    Minerva Neurosciences, Inc (NASDAQ:NERV) announced its earnings results on Tuesday, May, 13th. The biopharmaceutical company reported ($0.50) EPS for the quarter, topping analysts' consensus estimates of ($1.07) by $0.57.

    Shares of Minerva Neurosciences reverse split on the morning of Tuesday, June 21st 2022.The 1-8 reverse split was announced on Tuesday, June 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

    Shares of NERV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Minerva Neurosciences investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Meta Platforms (META), NIO (NIO), TherapeuticsMD (TXMD), Inovio Pharmaceuticals (INO) and VBI Vaccines (VBIV).

    Company Calendar

    Last Earnings
    5/13/2025
    Today
    8/08/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - DRUGS
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:NERV
    CIK
    1598646
    Fax
    N/A
    Employees
    9
    Year Founded
    2007

    Price Target and Rating

    High Price Target
    $5.00
    Low Price Target
    $5.00
    Potential Upside/Downside
    +178.6%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    $0.82
    Trailing P/E Ratio
    2.19
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    $1.44 million
    Net Margins
    N/A
    Pretax Margin
    N/A
    Return on Equity
    -20.68%
    Return on Assets
    15.73%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    9.21
    Quick Ratio
    9.21

    Sales & Book Value

    Annual Sales
    N/A
    Price / Sales
    N/A
    Cash Flow
    $0.21 per share
    Price / Cash Flow
    8.64
    Book Value
    ($3.67) per share
    Price / Book
    -0.49

    Miscellaneous

    Outstanding Shares
    6,990,000
    Free Float
    N/A
    Market Cap
    $12.55 million
    Optionable
    Not Optionable
    Beta
    -0.32

    Social Links

    7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

    Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

    Get This Free Report

    This page (NASDAQ:NERV) was last updated on 8/8/2025 by MarketBeat.com Staff
    From Our Partners